Insider Transactions Reported by 16 Insiders of BRAINSTORM CELL THERAPEUTICS INC.

Symbol
BCLI on OTC
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 10 Feb 2025

BRAINSTORM CELL THERAPEUTICS INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sankesh Abbhi Director $3,860,181 10 Dec 2021
Ralph Kern COO and Chief Medical Officer $396,174 06 Mar 2022
Malcolm Taub Director $137,195 15 Dec 2021
Chaim Lebovits President & CEO $76,232 01 Jan 2025
Kirk Taylor Chief Medical Officer $62,094 01 May 2023
June Sherie Almenoff Director $23,374 15 Dec 2021
Ibrahim B. Dagher Chief Medical Officer $18,130 01 Jan 2025
Uri Yablonka EVP & Chief Business Officer, Director $15,610 01 Jan 2025
Hartoun Hartounian EVP, Chief Operating Officer $11,856 01 Jan 2025
Stacy Lindborg Director $10,996 01 Jan 2025
Alla Patlis Interim Chief Financial Officer & Controller $10,112 01 Jan 2025
Jacob A. Frenkel Director $9,981 01 Jan 2025
Irit Arbel Director $9,360 01 Jan 2025
Nir Naor Director $7,174 01 Jan 2025
Anthony J. Polverino Director $5,866 01 Jan 2025
Menghisteab Bairu Director $5,472 01 Jan 2025

Recent Insider Transactions by Companies or Individuals for BRAINSTORM CELL THERAPEUTICS INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.